Prevention of type 2 diabetes mellitus: what do results of studies really mean?

Dopamine-agonists pramipexole (SIFROL) and ropinirole (ADARTEL) for restless legs syndrome

Immunotherapy of allergic diseases (II)

Once again: Do long-acting beta-2 agonists increase complications of asthma?

Statins for diabetic patients with end-stage renal disease?

Oral anticoagulants still first line antithrombotics in chronic atrial fibrillation
US: no approval of tibolone (LIVIELLA) for menopausal symptoms
Eyedrops: one is sufficient

Suicidality due to levofloxacin (TAVANIC) and other fluoroquinolones

Infliximab (REMICADE): hepatosplenic gammadelta T-cell lymphoma
Malformations by angiotensin-converting enzyme inhibitors during the first trimenon